Innovation, influence and business in America's medical cities.

Novia CareClinics LLC has raised $1 million in debt for its on-site, employer-affiliated health clinics, according to a regulatory filing. The company says it operates 18 clinics for 16 employers and is in the process of opening up six new clinics for six different employers.

The U.S. Food and Drug Administration cited Lilly for omitting and minimizing risk information about Cymbalta, and overstating the drug’s efficacy.

A company spokeswoman didn’t provide a reason for ex-CEO Michael Tillman’s departure and said a replacement would be identified “shortly.”

Zimmer Holdings Inc. (NYSE:ZMH) brought in a new president to lead its global business unit. Former Stryker Corp. (NYSE:SYK) executive Jeffrey Paulsen will lead the Warsaw, Ind.-based orthopedics giant’s international operations.

Positioning itself to take advantage of the well-documented nursing shortage, Orbis Educational Services Inc. has received an $8.65 million investment to further its nursing education programs.

Under the terms of the deal with publicly traded Incyte Corp., Lilly receives worldwide rights to develop and commercialize the compound as an oral treatment for all inflammatory conditions

In moves that Symmetry says will save $3.4 million annually, the company will close its Auburn, Maine, manufacturing plant and cut an unspecified number of its 2,500 worldwide employees.

Fresh off a $12 million fund-raise, sleep services and equipment provider Dormir Inc. has gone shopping, acquiring 15 sleep-therapy centers in the western United States for an undisclosed sum.

Kylin’s technology is based on what’s known as RNA interference, a technique for “gene silencing.”

The consumer health services provider has appointed former Indianapolis mayor Stephen Goldsmith to sit on its board of directors.